This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand:
* How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV
Patients of all ages with a confirmed diagnosis of RSV infection
Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024
Patients with documented data in the SEHA electronic medical record (EMR) system
Patients with suspected RSV infection that is not laboratory-confirmed
Patients without sufficient data in the SEHA EMR system
This study includes all patients of any age who have a laboratory-confirmed diagnosis of Respiratory Syncytial Virus (RSV) infection recorded in the SEHA electronic medical records between January 2018 and December 2024. The population spans from newborn infants to elderly adults, including those with underlying medical conditions such as chronic lung disease, heart disease, immunosuppression, and other comorbidities that may influence RSV severity. Both hospitalized patients and those diagnosed in outpatient settings within SEHA healthcare facilities are included. The study aims to represent the full spectrum of RSV disease burden, clinical outcomes, risk factors, long-term health impacts, and healthcare costs across diverse demographic groups in the UAE.
Cohort
Retrospective
Not listed
Burden of RSV Infection Across All Age Groups
Measurement of the incidence of confirmed RSV infections in patients of all ages using SEHA hospital data from January 2018 to December 2024.
Burden of RSV Infection Across All Age Groups
Measurement of the prevalence of confirmed RSV infections in patients of all ages using SEHA hospital data from January 2018 to December 2024.
Identification of Risk Factors for Severe RSV Infection
Analysis of clinical, demographic, and comorbidity data to identify key risk factors associated with severe RSV infection outcomes.
Proportion of Hospital Admissions Due to RSV
Evaluation of the percentage of total hospital admissions attributed to RSV infections.
ICU Admission Rates for RSV-Infected Patients
Measurement of the proportion of RSV patients requiring ICU care.
Financial Burden of RSV Infection
Assessment of direct medical costs associated with RSV hospitalization and ICU care.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
